Please login to the form below

Not currently logged in
Email:
Password:

Ligelizumab

This page shows the latest Ligelizumab news and features for those working in and with pharma, biotech and healthcare.

FDA approves new self-injection administration for Xolair

FDA approves new self-injection administration for Xolair

According to Novartis, ligelizumab binds to IgE with an 88-fold higher affinity than Xolair, with the two binding differently to the antibody. ... Novartis picked up ligelizumab following its acquisition of UK firm Ziarco in 2016.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...